Enrolling by Invitation
Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
NCT07154238
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
- Novo Nordisk Investigational Site Bad Oeynhausen, Germany